Full Text View
Tabular View
No Study Results Posted
Related Studies
Cytochrome P450 2E1 and Iron Overload
This study has been completed.
Study NCT00138684   Information provided by Rennes University Hospital
First Received: August 29, 2005   Last Updated: September 18, 2006   History of Changes

August 29, 2005
September 18, 2006
September 2003
 
chlorzoxazone metabolization rate before and after venesection
Same as current
Complete list of historical versions of study NCT00138684 on ClinicalTrials.gov Archive Site
 
 
 
Cytochrome P450 2E1 and Iron Overload
Cytochrome P450 2E1 and Iron Overload

The aim of the study is to determine, in patients presenting with insulin resistance and hepatic iron overload, the effects of venesection therapy on cytochrome P450 2E1 activity by comparing the rates of metabolization of chlorzoxazone before and after venesection.

 
 
Interventional
Allocation:  Randomized
Control:  Uncontrolled
Intervention Model:  Parallel Assignment
Masking:  Open Label
Primary Purpose:  Treatment
  • Insulin Resistance
  • Iron Overload
Procedure: venesection therapy
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
50
December 2005
 

Inclusion Criteria:

  • Male patients aged from 18 to 70 years
  • Hepatic iron overload measured by magnetic resonance imaging [MRI] (> 36 µmol/g)
  • Related to insulin resistance

Exclusion Criteria:

  • Excess alcohol consumption
  • Female gender
Male
18 Years to 70 Years
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00138684
 
DGS 2003/0052, PHRC/02-09, CIC0203/015
Rennes University Hospital
Ministry of Health, France
Study Chair: Jean-Michel Reymann, PhD CHU Rennes
Principal Investigator: Fabrice Lainé, MD CHU Rennes
Rennes University Hospital
September 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP